69,179 documents
liquidity and corporate governance requirements. Most Canadian publicly traded
document of their financial House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
liquidity and corporate governance requirements. Most Canadian publicly traded
Canadian stock markets vary significantly in terms
document Similar to stock markets in the United States House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Canadian stock markets vary significantly in terms
2016. The chart indicates that the stock price performance
document companies in Canada since September 30 House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
2016. The chart indicates that the stock price performance
as compared to Nasdaq and the NYSE. The following chart provides a comparison
document stringent requirements House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
as compared to Nasdaq and the NYSE. The following chart provides a comparison
Vitality Biopharma
document Vitality Biopharma House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCQB:VBIO 1.85 56.4% 42.7 41.9 0.1 –4.3 NM NM
Thc Therapeutics
document THC Therapeutics House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCPK:THCT 0.34 60.6% 39.7 39.7 0.0 0.0 NM NM
Sansal Wellness Holdings
document SanSal Wellness Holdings House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCPK:SSWH 0.95 29.6% 55.9 57.4 0.6 –1.5 NM NM
Praetorian Property
document Praetorian Property House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCPK:PRRE 0.52 75.8% 81.1 93.5 14.1 NA 6.6 NM
Player's Network
document Player's Network House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCQB:PNTV 0.08 66.1% 45.0 45.9 0.2 –4.7 NM NM
Pharmacyte Biotech
document PharmaCyte Biotech House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCQB:PMCB 0.05 71.6% 46.7 42.4 0.0 NA NM NM
Medicine Man Technologies
document Medicine Man Technologies House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCQB:MDCL 1.79 43.2% 39.2 39.0 2.4 –5.5 16.2 NM
Medical Marijuana
document Medical Marijuana House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCPK:MJNA 0.10 55.1% 307.1 317.7 8.0 –3.9 39.7 NM
Mcig
document mCig House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCQB:MCIG 0.17 66.1% 68.5 67.0 7.7 1.2 8.7 NM
Leafbuyer Technologies
document Leafbuyer Technologies House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCPK:LBUY 1.04 72.8% 39.9 39.8 0.9 NA 42.5 NM
Kush Bottles
document Kush Bottles House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCQB:KSHB 2.84 20.2% 170.4 170.2 18.8 0.8 9.1 NM
Ianthus Capital Holdings
document iAnthus Capital Holdings House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCQB:ITHU.F 1.64 39.1% 61.7 74.3 0.1 NA NM NM
Helix Tcs
document Helix TCS House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCPK:HLIX 3.00 76.9% 85.9 86.7 3.5 –3.0 24.9 NM
Gb Sciences
document GB Sciences House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCQB:GBLX 0.24 56.4% 31.3 37.0 0.2 –10.3 NM NM
Earth Science Tech
document Earth Science Tech House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCPK:ETST 0.81 79.5% 32.0 31.9 0.4 NA 74.1 NM
Corix Bioscience
document Corix Bioscience House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pp.
Inc. OTCQB:CXBS 1.19 45.9% 29.6 29.6 0.0 NA NM NM
